30 Day Trial
BARE BONES logo

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

Bioventus Launches GELSYN-3 HA for Treatment of Knee Osteoarthritis Pain -

Bioventus commenced U.S. launch of GELSYN-3™ three-injection hyaluronic acid for relief of pain associated with knee osteoarthritis. The regimen is intended to relieve pain for up to 6 months.

Bioventus acquired exclusive U.S. distribution rights for GELSYN from Institut Biochimique in 1Q16. The product had received FDA premarket approval in 2014.

Source: Bioventus LLC

Review Exhibit 115, the Viscosupplement Product Landscape, in THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT® for a matrix of products cleared and number of injections for various applications around the world.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.